| Author(s): | Hites, M Lapique, EL Massonnaud, CR Belhadi, D Jamard, S Goehringer, F Danion, F Reignier, J de Castro, N Garot, D Lacombe, K Tolsma, V Faure, E Malvy, D Staub, T Courjon, J Cazenave-Roblot, F Dyrhol Riise, AM Leturnier, P Martin-Blondel, G Roger, C Akinosoglou, K Moing, VL Piroth, L Sellier, P Lescure, X Trøseid, M Clevenbergh, P Dalgard, O Gallien, S Gousseff, M Loubet, P Vardon-Bounes, F Visée, C Belkhir, L Botelho-Nevers, É Cabié, A Kotanidou, A Lanternier, F Rouveix-Nordon, E Silva, S Thiery, G Poignard, P Carcelain, G Diallo, A Mercier, N Terzic, V Bouscambert-Duchamp, M Gaymard, A Trabaud, MA Destras, G Josset, L Billard, N Han, TH Guedj, J Couffin-Cadiergues, S Dechanet, A Delmas, C Esperou, H Fougerou-Leurent, C Mestre, SL Métois, A Noret, M Bally, I Dergan-Dylon, S Tubiana, S Kalif, O Bergaud, N Leveau, B Eustace, J Greil, R Hajdu, E Halanova, M Paiva, JA Piekarska, A|| Rodriguez Baño, J Tonby, K Trojánek, M Tsiodras, S Unal, S Burdet, C Costagliola, D Yazdanpanah, Y Peiffer-Smadja, N Mentré, F Ader, F DisCoVeRy study group |
| Title: | Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial |
| Publisher: | Elsevier |
| Issue Date: | 2024 |
| DOI: | 10.1016/j.jinf.2024.106120 |
| URI: | https://hdl.handle.net/10216/157559 |
| Source: | J Infect. 2024 Mar;88(3):106120. doi: 10.1016/j.jinf.2024.106120. Epub 2024 Feb 16. |
| Related Information: | info:eu-repo/grantAgreement/EC/H2020/101015736/EU |
| Document Type: | Outra Publicação em Revista Científica Internacional |
| Rights: | openAccess |
| License: | https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| Appears in Collections: | ISPUP - Outra Publicação em Revista Científica Internacional
|